Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)
Belite Bio (BLTE) posted quarterly Other Accumulated Expenses of $599000.0 for Q4 2025, up 4507.69% year-over-year from $13000.0 in Q4 2024, and up 4507.69% quarter-over-quarter from $13000.0 in Q4 2024.
Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
Belite Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $599000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 4507.69% year-over-year to $599000.0; the TTM figure through Dec 2025 stood at $599000.0 (up 4507.69% YoY), while the FY2025 annual figure was $599000.0, up 4507.69% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $599000.0, up from $13000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $599000.0 in Q4 2025, with the low at $13000.0 in Q4 2024.
- The 5-year median for Other Accumulated Expenses is $95000.0 (2021), against an average of $177800.0.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses slumped 87.96% in 2024, then surged 4507.69% in 2025.
- Belite Bio's Other Accumulated Expenses stood at $95000.0 in 2021, then retreated by 22.11% to $74000.0 in 2022, then soared by 45.95% to $108000.0 in 2023, then plunged by 87.96% to $13000.0 in 2024, then soared by 4507.69% to $599000.0 in 2025.
- Business Quant data shows BLTE's Other Accumulated Expenses at $599000.0 in Q4 2025, $13000.0 in Q4 2024, and $108000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 599,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 95,000.00 |